Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al.
Mulder
A B
AB
van den Bergh
F A J T M
FA
Vermes
I
I
D000483:Alleles; D000924:Anticholesteremic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics*; D019821:Simvastatin / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D019821:Simvastatin; D019389:Cytochrome P-450 CYP2D6